Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study)

Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study)

Oral semaglutide has potent anti-hyperglycemic efficacy in phase III trials. However, the complicated dosing instructions hamper to use this drug; therefore, we evaluated the efficacy and safety of oral semaglutide in subjects with type 2 diabetes in a real-world clinical setting. In this multi-cent...

Full description

Saved in:
Bibliographic Details
Main Authors: Sho Furusawa, Hiroshi Nomoto, Chiho Oba-Yamamoto, Jun Takeuchi, Miki Ito, Hiroyoshi Kurihara, Shin Aoki, Aika Miya, Hiraku Kameda, Akinobu Nakamura, Tatsuya Atsumi
Format: Article
Language:English
Published: The Japan Endocrine Society 2024-06-01
Series:Endocrine Journal
Subjects:
clinical trial
glucagon-like peptide-1 receptor agonist
glycemic control
type 2 diabetes
Online Access:https://www.jstage.jst.go.jp/article/endocrj/71/6/71_EJ23-0648/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items